Citing unsettled market conditions for health-care industrystocks, Meridian Diagnostics Inc. announced last week that ithas withdrawn its registration statement for the proposed saleof 2 million shares of common stock (NASDAQ:KITS). TheCincinnati company, which develops, manufactures andmarkets disposable immunodiagnostic kits for infectiousdiseases, filed the registration statement with the Securitiesand Exchange Commission on June 22.

(c) 1997 American Health Consultants. All rights reserved.